You gotta love the confidence now with which they tout Leronlimab’s MOA and treatment potential. They no longer seem to be cowering from the FDA and starting to blow our trumpet a bit more.

Now if only the SP would respond accordingly. Where the **** are all the new investors? It’s about time we saw more new names around here.